Approved Drugs
Showing 133–144 of 211 results
-
Approved Drugs
Nicardipine HCl | L-type Ca channel blocker / MDR inhibitor
Nicardipine (54527-84-3) is a clinically useful L-type calcium blocker. Inhibitor of MDR.2 References/Citations: 1) Merck 14 6495 2) Hulubei...$30.00 – $50.00 Select options -
Approved Drugs
Niclosamide | STAT3 signaling inhibitor
Niclosamide (50-65-7) reversibly inhibits mTORC1 signaling and stimulates autophagy.1 Inhibits activation and nuclear translocation of STAT3 select...$28.00 – $84.00 Select options -
Approved Drugs
Nifedipine | L-type Ca channel blocker
Nifedipine (21829-25-4) is a clinically useful L-type calcium blocker. References/Citations: 1) Vater et al., (1972), (Pharmacology of 4-(2'-...$40.00 – $122.00 Select options -
Apoptosis
Nilotinib | BCR-ABL inhibitor
Nilotinib (CAS 641571-10-0) is a novel, selective BCR-ABL inhibitor. More potent than imatinib against wild-type BCR-ABL (IC50 < 30 nM).1 Induc...$30.00 – $90.00 Select options -
Alzheimers
Nilvadipine | Syk inhibitor/Calcium channel blocker
Nilvadipine (75530-68-6) is a novel DHP L-type Ca2+ channel blocker that also inhibits Syk.1 Blocks Aβ production, APPβ secretion and reduces BACE-...$70.00 – $250.00 Select options -
Approved Drugs
Nimodipine | L-type calcium channel blocker
Nimodipine (66085-59-4) is an L-type calcium channel blocker.1 Prevents age-induced learning deficits in a rat model.2 Facilitates recovery of func...$50.00 – $180.00 Select options -
Approved Drugs
Nitrendipine | L-type Ca channel blocker
Nitrendipine (39562-70-4) is a clinically useful L-type calcium blocker. References/Citations: 1) Meyer et al., (1981), (Synthesis and compar...$75.00 – $200.00 Select options -
Approved Drugs
Olaparib | PARP1 inhibitor
Olaparib (763113-22-0) is a highly potent and selective PARP-inhibitor with IC50 values of 5 nM and 1 nM for PARP-1 and PARP-2, respectively.1 In ...$45.00 – $130.00 Select options